Transforming and Simplifying the Treatment of Pulmonary Embolism: “Safe Dose” Thrombolysis Plus New Oral Anticoagulants

Background Administration of systemic thrombolysis in pulmonary embolism (PE) has been limited to severe forms due to the risk of intracerebral hemorrhage (ICH). There is growing evidence from small studies that low-dose systemic thrombolysis has equal efficacy to standard dose, while eliminating th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung 2015-06, Vol.193 (3), p.369-374
Hauptverfasser:	Sharifi, Mohsen, Vajo, Zoltan, Freeman, Wilbur, Bay, Curt, Sharifi, Mirali, Schwartz, Frederic
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Dosage and administration Drug therapy Drug Therapy, Combination Embolisms Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Hemorrhage - chemically induced Hospitalization Humans Male Medicine Medicine & Public Health Methods Middle Aged Pneumology/Respiratory System Prospective Studies Pulmonary arteries Pulmonary embolism Pulmonary Embolism - blood Pulmonary Embolism - complications Pulmonary Embolism - diagnosis Pulmonary Embolism - drug therapy Pulmonary Embolism - physiopathology Pulmonary hypertension Recurrence Retrospective Studies Risk Factors Severity of Illness Index Thrombolytic therapy Thrombolytic Therapy - adverse effects Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!